American Century Companies’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.9M Buy
1,130,708
+37,954
+3% +$499K 0.01% 1219
2025
Q1
$15.7M Buy
1,092,754
+13,046
+1% +$188K 0.01% 1141
2024
Q4
$18.1M Sell
1,079,708
-59,838
-5% -$1M 0.01% 1101
2024
Q3
$18.2M Buy
1,139,546
+204,395
+22% +$3.27M 0.01% 1064
2024
Q2
$8.44M Buy
935,151
+12,031
+1% +$109K 0.01% 1312
2024
Q1
$10.4M Buy
923,120
+47,355
+5% +$535K 0.01% 1189
2023
Q4
$6.97M Buy
875,765
+180,880
+26% +$1.44M ﹤0.01% 1293
2023
Q3
$4.5M Buy
694,885
+23
+0% +$149 ﹤0.01% 1370
2023
Q2
$4.3M Buy
694,862
+180,746
+35% +$1.12M ﹤0.01% 1359
2023
Q1
$1.97M Sell
514,116
-312
-0.1% -$1.2K ﹤0.01% 1614
2022
Q4
$1.59M Sell
514,428
-1,318
-0.3% -$4.09K ﹤0.01% 1638
2022
Q3
$2.07M Sell
515,746
-1,831
-0.4% -$7.36K ﹤0.01% 1435
2022
Q2
$2.52M Buy
517,577
+342
+0.1% +$1.67K ﹤0.01% 1340
2022
Q1
$4.64M Buy
517,235
+112
+0% +$1.01K ﹤0.01% 1126
2021
Q4
$5.82M Buy
517,123
+146,831
+40% +$1.65M ﹤0.01% 1010
2021
Q3
$6.18M Sell
370,292
-1,212
-0.3% -$20.2K ﹤0.01% 976
2021
Q2
$8.25M Buy
+371,504
New +$8.25M 0.01% 875